Фармакологическая коррекция мексидолом изменений системы глутатиона у больных с сочетанной патологией

The clinical pharmacological investigation of mexidolum influence on the endogenic antioxidant protection in patiens of older age groups suffering from discirculatory encephalopathy and hypothyroidism of overage degree of severity has been performed. The predictor of pharmacotherapeutic correction of free radical processes by mexidolum is high concentration of glutathione in blood plasma and low activity of glutathione peroxidase in erythrocytes.